Subproject 3: Comparative Legal Analysis
A Scientific, Ethical and Comparative Legal Analysis of the Clinical Application of Human Induced Pluripotent Stem Cells in Germany and Austria (ClinhiPS) – SP3: Comparative Legal Analysis
University of Mannheim
Institute for German, European and International Medical Law, Public Health Law and Bioethics (IMGB)
Project number: 01GP1602A
Funds: 282,586.00 EUR
Term: 1 April 2016 – 31 March 2018
University of Vienna
Department of Medical Law of the Institute for Constitutional and Administrative Law of the University of Vienna (Faculty of Law)
Subproject 3 consists of a comparative legal analysis of the clinical application of human induced pluripotent stem cells (hiPSCs) in Germany and Austria. This subproject compares German and Austrian law, identifying legal similarities and differences in the clinical application of hiPSCs. In particular, it examines the legal requirements that need to be met in order to apply future hiPSC therapies in German and Austrian clinics.
Subproject 3 aims to identify legal flaws and gaps in the German regulatory approach and provide recommendations for action by the German legislator. A comprehensive legal guide for physicians, researchers and patients will also be created.